Catabasis Pharmaceuticals
13 clinical trials · Sponsor
◉ Watch Catabasis Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| An Open-Label Extension Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy (NCT03917719) | Catabasis Pharmaceuticals | 2019-03-14 |
| Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy (NCT03703882) | Catabasis Pharmaceuticals | 2018-10-02 |
Track Catabasis Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.